Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Stärke
Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Packungsgröße
Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Form
Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.